Abstracts of the eleventh annual meeting of the American society for apheresis San Francisco, California. March 8‐10, 1990
Identifieur interne : 001288 ( Main/Exploration ); précédent : 001287; suivant : 001289Abstracts of the eleventh annual meeting of the American society for apheresis San Francisco, California. March 8‐10, 1990
Auteurs :Source :
- Journal of Clinical Apheresis [ 0733-2459 ] ; 1990.
English descriptors
- Teeft :
- Active donors, Acute cholestasis, Adjuvant therapy, Adsorption, Adverse effects, Adverse events, Adverse reactions, Allo, Alternative forms, Anderson cancer center, Antiplatelet agents, Apheresis, Apheresis donors, Apheresis machine, Apheresis procedures, Apheresis program, Aplastic anemia, Artificial organs, Autoimmune diseases, Autologous, Autolymphocyte therapy, Barnes hospital blood bank, Blood cell, Blood collection, Blood pressure, Blood products, Blood ratio, Blood transfusion, Blood transfusions, Blood volume, Body weight, Bone marrow, Bone marrow concentration, Bone marrow processing, Bone marrow transplantation, Buffy coat, Cardiology research centre, Catheter, Cell cancers, Cell content, Cell exchange, Cell layer, Centre, Centrifuge speed, Chemotherapy, Cleveland clinic foundation, Clinic, Clinical application, Clinical benefit, Clinical chemistry, Clinical condition, Clinical responses, Clinical status, Clinical symptoms, Coagulation, Coagulation factors, Coagulation profile, Cobe, Cobe spectra, Collection efficiency, Collection time, Complement activation, Complement components, Consecutive procedures, Control group, Coronary arteries stenosis, Cryosupernatant plasma, Cutaneous lymphoma, Cyropreserved autologous, Data support, Donation, Donation time, Donor, Donor acceptance, Donor blood, Donor center, Donor groups, Donor procedures, Donor safety, Double access, Dual needle mode, Early engraftment, Effective method, Effective procedure, Effluent line, Engraftment, Erythropoietic protoporphyria, Evanston hospital, Exchange transfusion, Extracorporeal, Extracorporeal ldufibrinogen precipitation, Extracorporeal photopheresis, Extracorporeal system, Factor viii, Familial hypercholesterolemia, Fenwal, Fibrinogen, Fibrinogen levels, Filtration, Flow rate, Haemonetics, Hemapheresis, Hemapheresis procedures, Hemolysis, Heparin, Hudson valley blood services, Hypercholesterolemia, Hypotonic stress, Immune, Immune complexes, Immune hemolysis, Immune sciences, Immunoadsorption, Immunoglobulin, Immunosuppressive therapy, Imre corporation, Incompatible transplants, Infusion, Inner surface, Iowa city, Ivigg, Large number, Leukocyte, Leukocyte contamination, Leukocyte removal filters, Lowest incidence, Lung transplantation, Lymphocyte, Lymphocyte counts, Major reactions, Marrow, Marrow specimens, Medical center, Medical treatment, Menlo park, Monoclonal antibody covalently, Monoclonal gammopathy, Months survival, Multimeric analysis, Myasthenia gravis, Neurological function, Oklahoma blood institute, Operator intervention, Pbsc, Peak return line, Peripheral blood, Pheresis, Pheresis donors, Pittsburgh cancer center, Plasm, Plasma, Plasma donors, Plasma exchange, Plasma exchanges, Plasma perfusion, Plasma protein study, Plasma volumes, Plasmapheresis, Plasmapheresis treatment, Platelet, Platelet agents, Platelet count, Platelet counts, Platelet loss, Plateletpheresis, Plex, Plph, Polyester filter, Precipitation, Preliminary steps, Progressive modif, Protocol, Purification method, Purpura, Random plts, Rapid improvement, Regular treatment, Reinfusion phases, Relative risk, Renal, Renal cell carcinoma, Renal failure, Renal function, Replacement solution, Replacerrent fluid, Reticulocyte count, Same donor, Scientific centre, Secondary immunodeficiency, Seidel dept, Selective removal, Separation efficiency, Separation protocols, Separator, Side effects, Significant difference, Single access, Single needle mode, Sterile polystyrene chamber, Systemic lupus, Therapeutic plasma exchange, Third sample, Thrombin, Thrombotic episodes, Thrombotic thrombocytopenic purpura, Total bilirubin, Total cholesterol, Total plasma loss, Total volume, Toxicity, Transfusion, Transfusion medicine, Transfusion medicine physician, Transplant, Transplantation, Tumor recurrence, Type hypercholesterolemia, University clinics, Unrelated bone marrow donors, Ussr ministry, Vancouver, Venous, Venous access, Venous access failure, Wash procedure, Week period, Whole blood, Workplace, Workplace blood drives, York blood center.
Url:
DOI: 10.1002/jca.2920050308
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001918
- to stream Istex, to step Curation: 001802
- to stream Istex, to step Checkpoint: 001061
- to stream Main, to step Merge: 001292
- to stream Main, to step Curation: 001288
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstracts of the eleventh annual meeting of the American society for apheresis San Francisco, California. March 8‐10, 1990</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F034D75F4FA2DD661AD9B9E76FBB570D5045CF56</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1002/jca.2920050308</idno>
<idno type="url">https://api.istex.fr/document/F034D75F4FA2DD661AD9B9E76FBB570D5045CF56/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001918</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001918</idno>
<idno type="wicri:Area/Istex/Curation">001802</idno>
<idno type="wicri:Area/Istex/Checkpoint">001061</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001061</idno>
<idno type="wicri:Area/Main/Merge">001292</idno>
<idno type="wicri:Area/Main/Curation">001288</idno>
<idno type="wicri:Area/Main/Exploration">001288</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Abstracts of the eleventh annual meeting of the American society for apheresis San Francisco, California. March 8‐10, 1990</title>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Clinical Apheresis</title>
<title level="j" type="abbrev">J. Clin. Apheresis</title>
<idno type="ISSN">0733-2459</idno>
<idno type="eISSN">1098-1101</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">5</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="153">153</biblScope>
<biblScope unit="page" to="177">177</biblScope>
</imprint>
<idno type="ISSN">0733-2459</idno>
</series>
<idno type="istex">F034D75F4FA2DD661AD9B9E76FBB570D5045CF56</idno>
<idno type="DOI">10.1002/jca.2920050308</idno>
<idno type="ArticleID">JCA2920050308</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0733-2459</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Active donors</term>
<term>Acute cholestasis</term>
<term>Adjuvant therapy</term>
<term>Adsorption</term>
<term>Adverse effects</term>
<term>Adverse events</term>
<term>Adverse reactions</term>
<term>Allo</term>
<term>Alternative forms</term>
<term>Anderson cancer center</term>
<term>Antiplatelet agents</term>
<term>Apheresis</term>
<term>Apheresis donors</term>
<term>Apheresis machine</term>
<term>Apheresis procedures</term>
<term>Apheresis program</term>
<term>Aplastic anemia</term>
<term>Artificial organs</term>
<term>Autoimmune diseases</term>
<term>Autologous</term>
<term>Autolymphocyte therapy</term>
<term>Barnes hospital blood bank</term>
<term>Blood cell</term>
<term>Blood collection</term>
<term>Blood pressure</term>
<term>Blood products</term>
<term>Blood ratio</term>
<term>Blood transfusion</term>
<term>Blood transfusions</term>
<term>Blood volume</term>
<term>Body weight</term>
<term>Bone marrow</term>
<term>Bone marrow concentration</term>
<term>Bone marrow processing</term>
<term>Bone marrow transplantation</term>
<term>Buffy coat</term>
<term>Cardiology research centre</term>
<term>Catheter</term>
<term>Cell cancers</term>
<term>Cell content</term>
<term>Cell exchange</term>
<term>Cell layer</term>
<term>Centre</term>
<term>Centrifuge speed</term>
<term>Chemotherapy</term>
<term>Cleveland clinic foundation</term>
<term>Clinic</term>
<term>Clinical application</term>
<term>Clinical benefit</term>
<term>Clinical chemistry</term>
<term>Clinical condition</term>
<term>Clinical responses</term>
<term>Clinical status</term>
<term>Clinical symptoms</term>
<term>Coagulation</term>
<term>Coagulation factors</term>
<term>Coagulation profile</term>
<term>Cobe</term>
<term>Cobe spectra</term>
<term>Collection efficiency</term>
<term>Collection time</term>
<term>Complement activation</term>
<term>Complement components</term>
<term>Consecutive procedures</term>
<term>Control group</term>
<term>Coronary arteries stenosis</term>
<term>Cryosupernatant plasma</term>
<term>Cutaneous lymphoma</term>
<term>Cyropreserved autologous</term>
<term>Data support</term>
<term>Donation</term>
<term>Donation time</term>
<term>Donor</term>
<term>Donor acceptance</term>
<term>Donor blood</term>
<term>Donor center</term>
<term>Donor groups</term>
<term>Donor procedures</term>
<term>Donor safety</term>
<term>Double access</term>
<term>Dual needle mode</term>
<term>Early engraftment</term>
<term>Effective method</term>
<term>Effective procedure</term>
<term>Effluent line</term>
<term>Engraftment</term>
<term>Erythropoietic protoporphyria</term>
<term>Evanston hospital</term>
<term>Exchange transfusion</term>
<term>Extracorporeal</term>
<term>Extracorporeal ldufibrinogen precipitation</term>
<term>Extracorporeal photopheresis</term>
<term>Extracorporeal system</term>
<term>Factor viii</term>
<term>Familial hypercholesterolemia</term>
<term>Fenwal</term>
<term>Fibrinogen</term>
<term>Fibrinogen levels</term>
<term>Filtration</term>
<term>Flow rate</term>
<term>Haemonetics</term>
<term>Hemapheresis</term>
<term>Hemapheresis procedures</term>
<term>Hemolysis</term>
<term>Heparin</term>
<term>Hudson valley blood services</term>
<term>Hypercholesterolemia</term>
<term>Hypotonic stress</term>
<term>Immune</term>
<term>Immune complexes</term>
<term>Immune hemolysis</term>
<term>Immune sciences</term>
<term>Immunoadsorption</term>
<term>Immunoglobulin</term>
<term>Immunosuppressive therapy</term>
<term>Imre corporation</term>
<term>Incompatible transplants</term>
<term>Infusion</term>
<term>Inner surface</term>
<term>Iowa city</term>
<term>Ivigg</term>
<term>Large number</term>
<term>Leukocyte</term>
<term>Leukocyte contamination</term>
<term>Leukocyte removal filters</term>
<term>Lowest incidence</term>
<term>Lung transplantation</term>
<term>Lymphocyte</term>
<term>Lymphocyte counts</term>
<term>Major reactions</term>
<term>Marrow</term>
<term>Marrow specimens</term>
<term>Medical center</term>
<term>Medical treatment</term>
<term>Menlo park</term>
<term>Monoclonal antibody covalently</term>
<term>Monoclonal gammopathy</term>
<term>Months survival</term>
<term>Multimeric analysis</term>
<term>Myasthenia gravis</term>
<term>Neurological function</term>
<term>Oklahoma blood institute</term>
<term>Operator intervention</term>
<term>Pbsc</term>
<term>Peak return line</term>
<term>Peripheral blood</term>
<term>Pheresis</term>
<term>Pheresis donors</term>
<term>Pittsburgh cancer center</term>
<term>Plasm</term>
<term>Plasma</term>
<term>Plasma donors</term>
<term>Plasma exchange</term>
<term>Plasma exchanges</term>
<term>Plasma perfusion</term>
<term>Plasma protein study</term>
<term>Plasma volumes</term>
<term>Plasmapheresis</term>
<term>Plasmapheresis treatment</term>
<term>Platelet</term>
<term>Platelet agents</term>
<term>Platelet count</term>
<term>Platelet counts</term>
<term>Platelet loss</term>
<term>Plateletpheresis</term>
<term>Plex</term>
<term>Plph</term>
<term>Polyester filter</term>
<term>Precipitation</term>
<term>Preliminary steps</term>
<term>Progressive modif</term>
<term>Protocol</term>
<term>Purification method</term>
<term>Purpura</term>
<term>Random plts</term>
<term>Rapid improvement</term>
<term>Regular treatment</term>
<term>Reinfusion phases</term>
<term>Relative risk</term>
<term>Renal</term>
<term>Renal cell carcinoma</term>
<term>Renal failure</term>
<term>Renal function</term>
<term>Replacement solution</term>
<term>Replacerrent fluid</term>
<term>Reticulocyte count</term>
<term>Same donor</term>
<term>Scientific centre</term>
<term>Secondary immunodeficiency</term>
<term>Seidel dept</term>
<term>Selective removal</term>
<term>Separation efficiency</term>
<term>Separation protocols</term>
<term>Separator</term>
<term>Side effects</term>
<term>Significant difference</term>
<term>Single access</term>
<term>Single needle mode</term>
<term>Sterile polystyrene chamber</term>
<term>Systemic lupus</term>
<term>Therapeutic plasma exchange</term>
<term>Third sample</term>
<term>Thrombin</term>
<term>Thrombotic episodes</term>
<term>Thrombotic thrombocytopenic purpura</term>
<term>Total bilirubin</term>
<term>Total cholesterol</term>
<term>Total plasma loss</term>
<term>Total volume</term>
<term>Toxicity</term>
<term>Transfusion</term>
<term>Transfusion medicine</term>
<term>Transfusion medicine physician</term>
<term>Transplant</term>
<term>Transplantation</term>
<term>Tumor recurrence</term>
<term>Type hypercholesterolemia</term>
<term>University clinics</term>
<term>Unrelated bone marrow donors</term>
<term>Ussr ministry</term>
<term>Vancouver</term>
<term>Venous</term>
<term>Venous access</term>
<term>Venous access failure</term>
<term>Wash procedure</term>
<term>Week period</term>
<term>Whole blood</term>
<term>Workplace</term>
<term>Workplace blood drives</term>
<term>York blood center</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001288 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001288 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sarre |area= MusicSarreV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:F034D75F4FA2DD661AD9B9E76FBB570D5045CF56 |texte= Abstracts of the eleventh annual meeting of the American society for apheresis San Francisco, California. March 8‐10, 1990 }}
This area was generated with Dilib version V0.6.33. |